(Q44643066)

5 December 2017

title

Carcinogenetic risk estimation based on quantification of DNA methylation levels in liver tissue at the precancerous stage (English)

1 reference

5 December 2017

0 references

6

Yae Kanai

1 reference

5 December 2017

2

Eri Arai

1 reference

5 December 2017

Ryo Nagashio

1

1 reference

5 December 2017

Hidenori Ojima

series ordinal

3

1 reference

5 December 2017

Tomoo Kosuge

series ordinal

4

1 reference

5 December 2017

Yutaka Kondo

series ordinal

5

1 reference

5 December 2017

language of work or name

English

0 references

publication date

9 May 2011

1 reference

International Journal of Cancer

5 December 2017

published in

1 reference

5 December 2017

volume

129

1 reference

5 December 2017

issue

5

1 reference

5 December 2017

page(s)

1170-1179

1 reference

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

5 December 2017

cites work

1 reference

A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades

21 January 2018

1 reference

The epigenomics of cancer

21 January 2018

1 reference

21 January 2018

Epigenetics in cancer

1 reference

Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state

21 January 2018

1 reference

Alterations of DNA methylation and clinicopathological diversity of human cancers

21 January 2018

1 reference

Aberrant DNA methylation on chromosome 16 is an early event in hepatocarcinogenesis.

21 January 2018

1 reference

Detection of hypermethylation of the p16(INK4A) gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus

21 January 2018

1 reference

Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis

21 January 2018

1 reference

Genome-wide DNA methylation profiles in precancerous conditions and cancers

21 January 2018

1 reference

DNA methylation profiles in precancerous tissue and cancers: carcinogenetic risk estimation and prognostication based on DNA methylation status

21 January 2018

1 reference

Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification

21 January 2018

1 reference

Epigenetic silencing of prostaglandin E receptor 2 (PTGER2) is associated with progression of neuroblastomas

21 January 2018

1 reference

Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma

21 January 2018

1 reference

Genome-wide DNA methylation profiles in both precancerous conditions and clear cell renal cell carcinomas are correlated with malignant potential and patient outcome

21 January 2018

1 reference

Genome-wide DNA methylation profiles in liver tissue at the precancerous stage and in hepatocellular carcinoma.

21 January 2018

1 reference

Genome-wide DNA methylation profiles in urothelial carcinomas and urothelia at the precancerous stage

21 January 2018

1 reference

A bacterial artificial chromosome library for sequencing the complete human genome

21 January 2018

1 reference

High sensitivity mapping of methylated cytosines

21 January 2018

1 reference

Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas

21 January 2018

1 reference

Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?

21 January 2018

1 reference

Tackling the methylome: recent methodological advances in genome-wide methylation profiling

21 January 2018

1 reference

Genetics and epigenetics: stability and plasticity during cellular differentiation

21 January 2018

1 reference

Benefit of interferon therapy in hepatocellular carcinoma prevention for individual patients with chronic hepatitis C.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.26061

1 reference

5 December 2017

1 reference